Correlation between structural heart disease and cardiac SARS-CoV-2 manifestations
Nägele, Graber et al. evaluate cardiac manifestations of SARS-CoV-2 in patients with structural heart disease. The authors find that detection of SARS-CoV-2 in heart tissue is associated with poorer survival.
Main Authors: | Felix Nägele, Michael Graber, Jakob Hirsch, Leo Pölzl, Sabina Sahanic, Manuel Fiegl, Dominik Hau, Clemens Engler, Sophia Lechner, Anna Katharina Stalder, Kirsten D. Mertz, Jasmin D. Haslbauer, Alexandar Tzankov, Michael Grimm, Ivan Tancevski, Johannes Holfeld, Can Gollmann-Tepeköylü |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-022-00204-6 |
Similar Items
-
Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
by: Michael Graber, et al.
Published: (2022-05-01) -
Defining a therapeutic range for regeneration of ischemic myocardium via shock waves
by: Leo Pölzl, et al.
Published: (2021-01-01) -
Complexity of coronary artery disease and the release of cardiac biomarkers after CABG
by: Leo Pölzl, et al.
Published: (2024-02-01) -
Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial
by: Leo Pölzl, et al.
Published: (2020-05-01) -
The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza
by: Sabina Sahanic, et al.
Published: (2021-07-01)